Deferasirox Oral Granule
Product Images NDC 67877-675

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Deferasirox Oral (NDC 67877-675). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Defera Carton 180mg

Deferasirox Oral Granules 180 mg carton label for a 30-sachet package. Each sachet contains granules equivalent to 180 mg deferasirox. The label states Rx only, with patient instructions, storage information, and directions for pharmacist dispensing. Manufactured by Akem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Parsippany, NJ.*

FDA Label Image

Defera Carton 360mg

Packaging label for Deferasirox Oral Granules 360 mg by Ascend Laboratories, LLC. The label indicates each sachet contains 620 mg granule equivalent to 360 mg deferasirox, with 30 sachets per container. It includes administration instructions, pharmacist dispensing guidance, and manufacturer details for Akem Laboratories Ltd., India, distributed by Ascend Laboratories in Parsippany, NJ.*

FDA Label Image

Defera Carton 90mg

Deferasirox Oral Granules 90 mg packaging label showing a carton design for 30 sachets. The label includes patient instructions for use, dosage information, and pharmacist guidance. Manufactured by Akem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC.*

FDA Label Image

Defera-fig1 (Defera Fig1)

A bar chart showing changes in liver iron concentration (mg Fe/g dw) and serum ferritin (mcg/L) following various doses of Deferasirox tablets for oral suspension, ranging from 5 to 30 mg/kg/day. Liver iron content changes are represented by white bars, and serum ferritin changes by black bars, with corresponding sample sizes for each dose group indicated.*

FDA Label Image

Defera Sachet 180mg

Label for Deferasirox Oral Granules 180 mg by Ascend Laboratories, LLC. The label states each sachet contains 310 mg granules equivalent to 180 mg deferasirox. It includes the NDC number 67877-676-72 and notes it is Rx only. The manufacturer is Alkem Laboratories Ltd., India. A barcode and placeholder for batch coding are also present.*

FDA Label Image

Defera Sachet 360mg

Deferasirox Oral Granules 360 mg sachet label showing each sachet contains granules equivalent to 360 mg deferasirox. The label includes the NDC number 67877-677-73, manufacturer Alkem Laboratories Ltd., India, and Ascend Laboratories, LLC as the labeler. It features a barcode and a space labeled for batch coding.*

FDA Label Image

Defera Sachet 90mg

Label for Deferasirox Oral Granules 90 mg by Ascend Laboratories, LLC. The label states each sachet contains granules equivalent to 90 mg deferasirox. Includes NDC 67877-675-71 and manufacturing details indicating Alkem Laboratories Ltd., India. A barcode is displayed along with space for batch coding.*

FDA Label Image

Defera-structure (Defera Structure)

Chemical structure diagram of Deferasirox, the active ingredient in Deferasirox oral granules. The structure shows detailed atomic bonding and arrangement of the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.